三瑞乐片的避孕和治疗。

Therapia Hungarica (English edition) Pub Date : 1991-01-01
J Adám
{"title":"三瑞乐片的避孕和治疗。","authors":"J Adám","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Tri Regol has been used as a contraceptive during 541 cycles of 108 women and in further 73 cases for normalizing cycle anomalies or improving tablet tolerance. Pregnancy did not occur. The side-effects were insignificant. The triphasic therapy proved to be effective in all three fields. The author has mentioned the critical attitude towards oral contraceptives and calls the attention to the importance of an objective evaluation of the usefulness of these tablets. He emphasizes that the use of the multiphasic, low-dose pills is at present most up-to-date contraceptive method.</p>","PeriodicalId":76737,"journal":{"name":"Therapia Hungarica (English edition)","volume":"39 2","pages":"75-7"},"PeriodicalIF":0.0000,"publicationDate":"1991-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Contraception and therapy with Tri Regol tablet.\",\"authors\":\"J Adám\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Tri Regol has been used as a contraceptive during 541 cycles of 108 women and in further 73 cases for normalizing cycle anomalies or improving tablet tolerance. Pregnancy did not occur. The side-effects were insignificant. The triphasic therapy proved to be effective in all three fields. The author has mentioned the critical attitude towards oral contraceptives and calls the attention to the importance of an objective evaluation of the usefulness of these tablets. He emphasizes that the use of the multiphasic, low-dose pills is at present most up-to-date contraceptive method.</p>\",\"PeriodicalId\":76737,\"journal\":{\"name\":\"Therapia Hungarica (English edition)\",\"volume\":\"39 2\",\"pages\":\"75-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapia Hungarica (English edition)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapia Hungarica (English edition)","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在108名妇女的541个周期中使用Tri Regol作为避孕药,另有73例用于使周期异常正常化或改善片剂耐受性。没有怀孕。副作用微不足道。三段式治疗在这三个领域都被证明是有效的。作者提到了对口服避孕药的批评态度,并提请注意对这些药片的有用性进行客观评价的重要性。他强调,使用多相低剂量避孕药是目前最先进的避孕方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Contraception and therapy with Tri Regol tablet.

Tri Regol has been used as a contraceptive during 541 cycles of 108 women and in further 73 cases for normalizing cycle anomalies or improving tablet tolerance. Pregnancy did not occur. The side-effects were insignificant. The triphasic therapy proved to be effective in all three fields. The author has mentioned the critical attitude towards oral contraceptives and calls the attention to the importance of an objective evaluation of the usefulness of these tablets. He emphasizes that the use of the multiphasic, low-dose pills is at present most up-to-date contraceptive method.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信